The Oncosearch | Oncotarget

Correction: Protein phosphatase 1 regulatory subunit 1A regulates cell cycle progression in Ewing sarcoma Correction

Wen Luo, Changxin Xu, Sarah Phillips, Aliza Gardenswartz, Jeremy M. Rosenblum, Janet Ayello, Stephen L. Lessnick, Huai-Xiang Hao, Mitchell S. Cairo

Published Mar 3, 2023

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Review

Christian Mark Farag, Ryan Antar, Sinan Akosman, Matthew Ng, Michael J. Whalen

Published Feb 15, 2023 · Vol. 14, No. 1 · pp. 153-172

Keywords: HALP score, biomarker, prognosis, cancer, survival

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability Research Paper

Clark G. Wang, Malalage N. Peiris, April N. Meyer, Katelyn N. Nelson, Daniel J. Donoghue

Published Feb 6, 2023 · Vol. 14, No. 1 · pp. 133-145

Keywords: oncogenic fusion protein, chromosomal translocation, glioblastoma, FGFR3-TACC3, coiled-coil

Correction: KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer Correction

Keisuke Taniuchi, Mitsunari Ogasawara

Published Feb 3, 2023 · Vol. 14, No. 1 · pp. 104-104

Correction: Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR Correction

Carminia Maria Della Corte, Umberto Malapelle, Elena Vigliar, Francesco Pepe, Giancarlo Troncone, Vincenza Ciaramella, Teresa Troiani, Erika Martinelli, Valentina Belli, Fortunato Ciardiello, Floriana Morgillo

Published Dec 29, 2022 · Vol. 13, No. 1 · pp. 1369-1369

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Tomofumi Miura, Shuichi Mitsunaga, Juntaro Matsuzaki, Satoko Takizawa, Ken Kato, Atsushi Ochiai, Takahiro Ochiya

Published Nov 29, 2022 · Vol. 13, No. 1 · pp. 1341-1349

Keywords: microRNA, early palliative care, integration, cancer, referral

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Tomofumi Miura, Shuichi Mitsunaga, Juntaro Matsuzaki, Satoko Takizawa, Ken Kato, Atsushi Ochiai, Takahiro Ochiya

Published Nov 29, 2022

Keywords: microRNA, early palliative care, integration, cancer, referral

Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors Addendum

Venkata S.K. Manem, Olga Sazonova, Andréanne Gagné, Michèle Orain, Babak Khoshkrood-Mansoori, Nathalie Gaudreault, Yohan Bossé, Philippe Joubert

Published Nov 23, 2022 · Vol. 13, No. 1 · pp. 1302-1302

Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study Addendum

Connor Willis, Hillevi Bauer, Trang H. Au, Jyothi Menon, Sudhir Unni, Dao Tran, Zachary Rivers, Wallace Akerley, Matthew B. Schabath, Firas Badin, Ashley Sekhon, Malini Patel, Bing Xia, Beth Gustafson, John L. Villano, John-Michael Thomas, Solomon J. Lubinga, Michael A. Cantrell, Diana Brixner, David Stenehjem

Published Nov 18, 2022 · Vol. 13, No. 1 · pp. 1306-1306

Retraction: TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling Retraction

Yun Peng, Jun Cao, Xiao-Yi Yao, Jian-Xin Wang, Mei-Zuo Zhong, Ping-Ping Gan, Jian-Huang Li

Published Nov 16, 2022 · Vol. 13, No. 1 · pp. 1301-1301

Addendum: Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles Addendum

Zhouyu Zhu, Tao Yu, Ying Chai

Published Nov 15, 2022 · Vol. 13, No. 1 · pp. 1271-1271

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway Research Paper

Jen-Chieh Lee, Shu Liu, Yucheng Wang, You Liang, David M. Jablons

Published Oct 26, 2022 · Vol. 13, No. 1 · pp. 1217-1236

Keywords: AML, CDK8, kinase inhibitor, STAT pathway, xenograft

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Jun Gong, Michelle Guan, Haesoo Kim, Natalie Moshayedi, Sejal Mehta, Galen Cook-Wiens, Brent K. Larson, Jenny Zhou, Rishi Patel, Isaac Lapite, Veronica R. Placencio-Hickok, Richard Tuli, Ronald B. Natale, Andrew E. Hendifar

Published Oct 25, 2022 · Vol. 13, No. 1 · pp. 1202-1214

Keywords: hyaluronan, hyaluronic acid, biomarker, prognostic, predictive

FSP1, a novel KEAP1/NRF2 target gene regulating ferroptosis and radioresistance in lung cancers Research Perspective

Nsengiyumva Emmanuel, Hongen Li, Jing Chen, Yilei Zhang

Published Oct 17, 2022 · Vol. 13, No. 1 · pp. 1136-1139

Keywords: KEAP1/NRF2, lung cancer, ferroptosis, radioresistance, therapy

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition Addendum

Marcel Kemper, Georg Evers, Arik Bernard Schulze, Jan Sperveslage, Christoph Schülke, Georg Lenz, Thomas Herold, Wolfgang Hartmann, Hans-Ulrich Schildhaus, Annalen Bleckmann

Published Oct 13, 2022 · Vol. 13, No. 1 · pp. 1216-1216

Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models Research Paper

Diala Ghazal, Fatma Zalzala, John C. Fisk, Swetha Tati, Loukia G. Karacosta, Susan Morey, James R. Olson, Sally Quataert, Grace K. Dy, Kate Rittenhouse-Olson

Published Oct 7, 2022 · Vol. 13, No. 1 · pp. 1155-1164

Keywords: hJAA-F11, TF-Ag, Thomsen-Friedenreich antigen, tumor immunotherapy, translational oncology

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program Research Paper

Reyes Bernabé-Caro, Pilar Garrido, Rosario García-Campelo, Ramón Palmero, Ángel Artal, Cristina Bayona, Delvys Rodríguez-Abreu, Marta López-Brea, Alfredo Paredes, David Vicente, José Miguel Sánchez Torres, Margarita Majem, Pilar Diz, Rocío Gordo, Margarita Coca, Javier de Castro

Published Jun 7, 2022 · Vol. 13, No. 1 · pp. 812-827

Keywords: ALK-positive NSCLC, ALK inhibitor, crizotinib, alectinib, unselected patient

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Research Paper

Birgitta Hiddinga, Karen Zwaenepoel, Annelies Janssens, Jan Van Meerbeeck, Patrick Pauwels

Published May 13, 2022 · Vol. 13, No. 1 · pp. 800-809

Keywords: MGMT promoter methylation, anaplastic lymphoma kinase, neuroendocrine tumor, neuroendocrine carcinoma, small cell lung cancer

Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells Correction

Ilaria Guerriero, Daniela D’Angelo, Pierlorenzo Pallante, Mafalda Santos, Marianna Scrima, Donatella Malanga, Carmela De Marco, Maria Ravo, Alessandro Weisz, Carmelo Laudanna, Michele Ceccarelli, Geppino Falco, Antonia Rizzuto, Giuseppe Viglietto

Published May 11, 2022 · Vol. 13, No. 1 · pp. 755-755

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach Research Paper

Pooja Gulhane, Prajakta Nimsarkar, Komal Kharat, Shailza Singh

Published May 7, 2022 · Vol. 13, No. 1 · pp. 725-746

Keywords: non-small cell lung cancer, miRNAs, miR-520c-3p, PI3K/AKT signaling pathway, therapeutic targeting

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Correction: Protein phosphatase 1 regulatory subunit 1A regulates cell cycle progression in Ewing sarcoma Correction

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Review

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability Research Paper

Correction: KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer Correction

Correction: Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR Correction

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors Addendum

Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study Addendum

Retraction: TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling Retraction

Addendum: Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles Addendum

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway Research Paper

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

FSP1, a novel KEAP1/NRF2 target gene regulating ferroptosis and radioresistance in lung cancers Research Perspective

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition Addendum

Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models Research Paper

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program Research Paper

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Research Paper

Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells Correction

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Correction: Protein phosphatase 1 regulatory subunit 1A regulates cell cycle progression in Ewing sarcoma Correction

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Review

Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability Research Paper

Correction: KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer Correction

Correction: Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR Correction

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients Research Paper

Addendum: Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors Addendum

Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study Addendum

Retraction: TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling Retraction

Addendum: Multiple primary lung cancer displaying different EGFR and PTEN molecular profiles Addendum

MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway Research Paper

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

FSP1, a novel KEAP1/NRF2 target gene regulating ferroptosis and radioresistance in lung cancers Research Perspective

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition Addendum

Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models Research Paper

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program Research Paper

Are anaplastic lymphoma kinase (ALK) and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation driver biomarkers of pulmonary neuroendocrine tumors (NETs) and carcinomas (NECs)? Research Paper

Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells Correction

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach Research Paper